376. COVID-19 Severity in HIV+ Patients Receiving Tenofovir
نویسندگان
چکیده
منابع مشابه
Evaluation of COVID-19 incidence in psoriatic patients receiving Adalimumab
Background: Adalimumab is a highly human monoclonal antibody that binds to tumor necrosis factor, a key proinflammatory cytokine pathogenic in psoriasis. It considers an influential factor in controlling moderate to severe psoriasis. This study aimed to evaluate the impact of Adalimumab on COVID-19 incidence in patients with psoriasis. Methods: This cross-sectional study was performed at Baqiy...
متن کاملThe Relationship between Work Ability and Severity of Disease in Patients Recovering from Covid-19
Introduction. The work ability index based on a person 's health statuse predicts the ability to continue working now and in near feature. proper assessment of work ability in covid 19 recoveries is important for both patients and employers and its enhancement leads to the efficiency of human resourses in industries and organizations. The working staff’s efficiency is a matter of their work ab...
متن کاملComorbidity Affecting the Severity of COVID-19 Infection in Iraq
Aims: COIVD-19 Patients suffering from other diseases such as diabetic mellitus, asthma and obstructive pulmonary disease have increased morbidity and mortality rates resulting in more hospitalization and intensive therapy unit admissions. The study aimed to characterise and investigate the clinical pattern and the severity of symptoms in COVID-19 patients and to study its relationship with the...
متن کاملComment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
The combination of nucleos(t)ide analogues (NAs) is essential for the design of effective antiretroviral regimens. Although there are currently many options for the selection of such drug backbones, not all combinations display optimal results. As the number of these compounds has increased, it has become clear that the concomitant administration of certain NAs should be avoided due to high rat...
متن کاملClinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir.
BACKGROUND Tenofovir is part of the preferred first-line regimen for HIV-infected patients in South Africa (SA), but is associated with kidney toxicity. SA antiretroviral therapy (ART) guidelines recommend creatinine monitoring at baseline (ART start) and at 3, 6 and 12 months, and substituting tenofovir with zidovudine, stavudine or abacavir should creatinine clearance (CrCl) decrease to <5...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Open Forum Infectious Diseases
سال: 2020
ISSN: 2328-8957
DOI: 10.1093/ofid/ofaa439.571